RecruitingNot ApplicableNCT06648733
Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care (Optimierung Der Pharmakologischen Überleitung Von Palliativpatient:Innen Von stationär Nach Ambulant)
Sponsor
University Hospital Muenster
Enrollment
200 participants
Start Date
Jun 20, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
- advanced, malignant tumour disease
- advanced, chronic obstructive pulmonary disease
- Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
Exclusion Criteria1
- Impossibility of understanding the information and declaration of consent.
Interventions
OTHERStructured pharmaceutical discharge management
These patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06648733
Related Trials
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT068355699 locations
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT043337063 locations
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT0653305951 locations
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT070727283 locations
Positron Emission Tomography (PET) Imaging of Thrombosis
NCT038303201 location